“A Vancouver biotech company has partnered with one of the world’s largest pharmaceutical companies to develop a treatment for COVIDcampaign-pages/bispecifics/-19. As Ted Chernecki reports, Abcellera is hoping to start clinical trials in just a few months.”
Read full coverage on Global News.